These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19225353)

  • 21. Variability in doses obtained from a multi-dose ophthalmic solution: a potential source of error in the assessment of compliance.
    Winters JE; Castells DD; Lesher GA
    Optometry; 2001 Mar; 72(3):185-8. PubMed ID: 11294590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of disease severity on quality of eye-drop administration in patients with glaucoma or ocular hypertension.
    Aptel F; Masset H; Burillon C; Robin A; Denis P
    Br J Ophthalmol; 2009 May; 93(5):700-1. PubMed ID: 19395633
    [No Abstract]   [Full Text] [Related]  

  • 25. Drop instillation and glaucoma.
    Davis SA; Sleath B; Carpenter DM; Blalock SJ; Muir KW; Budenz DL
    Curr Opin Ophthalmol; 2018 Mar; 29(2):171-177. PubMed ID: 29140818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical therapies for glaucoma and ocular hypertension: an update on current practice.
    Rouland JF
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S1-4. PubMed ID: 14628758
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.
    Yee RW
    Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
    Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Black eye drop bottle tips improve compliance.
    Stack RR; McKellar MJ
    Clin Exp Ophthalmol; 2004 Feb; 32(1):39-41. PubMed ID: 14746589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chronic topical glaucoma medications on aerobic conjunctival bacterial flora.
    Sen EM; Yilmaz MB; Dansuk Z; Aksakal FN; Altinok A; Tuna T; Koklu G
    Cornea; 2009 Apr; 28(3):266-70. PubMed ID: 19387226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Force requirements in topical medicine use--the squeezability factor.
    Connor AJ; Severn PS
    Eye (Lond); 2011 Apr; 25(4):466-9. PubMed ID: 21293499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drop size of commercial glaucoma medications.
    Lederer CM; Harold RE
    Am J Ophthalmol; 1986 Jun; 101(6):691-4. PubMed ID: 3717253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TRAVATAN Dosing Aid accurately records when drops are taken.
    Friedman DS; Jampel HD; Congdon NG; Miller R; Quigley HA
    Am J Ophthalmol; 2007 Apr; 143(4):699-701. PubMed ID: 17386285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mist delivery of eye medication to the anterior segment.
    Collins JF; Dartt DA; Dana R
    Am J Ophthalmol; 2007 Jul; 144(1):137-9. PubMed ID: 17601439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor.
    St Peter DM; Steger JS; Patnaik JL; Davis N; Kahook MY; Seibold LK
    Med Devices (Auckl); 2023; 16():71-79. PubMed ID: 37056302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient bottle adaptation provides for adjustment of ophthalmic drop volume and drug dosage.
    Gaynes BI
    Clin Exp Ophthalmol; 2014; 42(7):704-5. PubMed ID: 24612119
    [No Abstract]   [Full Text] [Related]  

  • 39. Aids for eye drop administration.
    Davies I; Williams AM; Muir KW
    Surv Ophthalmol; 2017; 62(3):332-345. PubMed ID: 28011246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-administration of eye drops. a patient's view.
    Gebhardt DO
    Am J Ophthalmol; 2003 Oct; 136(4):778; author reply 778. PubMed ID: 14516846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.